Hexarelin protects H9c2 cardiomyocytes from doxorubicin-induced cell death

Endocrine

Volumn 14, Issue 1, 2001, Pages 113-119

  Filigheddu, N ^a   Fubini, A ^a   Baldanzi, G ^a   Cutrupi, S ^a   Ghe C ^a   Catapano, F ^a   Broglio, F ^a   Bosia, A ^a   Papotti, M ^a   Muccioli, G ^a   Ghigo, E ^a   Deghenghi, R ^a   Graziani, A ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Apoptosis; Cardiomyocytes; Doxorubicin; Growth hormone releasing peptides; Hexarelin

Indexed keywords

DOXORUBICIN; GROWTH HORMONE DERIVATIVE; GROWTH HORMONE SECRETAGOGUE; HEXARELIN; IBUTAMOREN; TYROSYLALANYLHEXARELIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BINDING; DRUG EFFECT; ENDOTHELIUM CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 17744371838     PISSN: 1355008X     EISSN: None     Source Type: Journal    
DOI: 10.1385/ENDO:14:1:113     Document Type: Article

References (22)